glp-1

https://www.urologytimes.com/view/pearls-perspectives-urology-role-in-glp-1-ra-treatments-with-hossein-sadeghi-nejad-md-and-nathalie-eid-ba In this 2-part episode of Pearls and Perspectives from the American Urological Association's (AUA) 2025 Annual Meeting in Las Vegas, NV, host Amy Pearlman...

https://www.cnbc.com/2025/04/25/novo-nordisk-legal-win-bars-many-compounded-wegovy-ozempic-drugs.html Key Points Novo Nordisk scored a huge legal victory that largely restricts compounding pharmacies from marketing or selling cheaper, unapproved versions of the drugmaker’s blockbuster weight...

The guest speakers says it all LOL! The Obesity Society (TOS) convened a panel of leading experts in obesity medicine, pharmacy, and regulatory law on March 19, 2025, to discuss the growing concerns surrounding the use of compounded GLP-1s for weight management and diabetes treatment. The...

In this episode, Dr. Rena Malik, MD, and Dr. Alexandra Sowa dive into the transformative effects of new obesity medications, highlighting dramatic weight loss results and their profound impact on personal and romantic relationships. They explore both the psychological and social dimensions...

New research suggests that GLP-1s may be effective in treating asthma. Drs Akshay Jain and James Kim discuss the impact of incretin therapy on the lung.

SURMOUNT-OSA Results: 'Impressive' in Improving Sleep Apnea Drs Akshay Jain and James Kim discuss the benefits of GLP-1 therapy for sleep apnea, as reported from the SURMOUNT-OSA trial. Key Insights from the Surmount OSA Study: Implications for Primary Care and Endocrinology Introduction Dr...

Ross Arena, PhD, Professor and Head of the Department of Physical Therapy, College of Applied Health Sciences, at the University of Illinois at Chicago, reviews his article appearing in the December 2024 issue of Mayo Clinic Proceedings, where he finds promise in the newly emerging medical...

Ozempic, Wegovy and Mounjaro are turning out to be some of the most successful drugs ever churned out by pharmaceutical companies. That’s because when it comes to treating type 2 diabetes and causing weight loss, they really do work. Sales are set to soar to even greater heights because...

Presenter: Suman Srinivasa, MD, MS The IAS–USA Annual Update on HIV Management in Chicago, Illinois May 16, 2024 Harnessing GLP-1 Receptor Agonists for Weight Management in HIV Patients: Insights from Dr. Suman Shrinivasa In a highly anticipated session, Dr. Suman Shrinivasa, Assistant...

https://www.prnewswire.com/news-releases/nubioage-nuhx-and-marius-pharmaceuticals-team-up-for-collaborative-glp-1-comparison-study-in-male-patients-302257781.html WEST PALM BEACH, Fla., Sept. 25, 2024 /PRNewswire/ -- nuBioAge, a longevity science and wellness network based in West Palm Beach...

Tirzepatide and semaglutide are both injectable medications used for weight loss and type 2 diabetes management, but they differ in their mechanisms of action and effectiveness. Here's a comparison of the two drugs: Mechanism of Action Tirzepatide: Dual glucose-dependent insulinotropic...

https://www.vumedi.com/video/aua-2024-insights-glp-1-receptor-agonists-and-mens-health/

Obesity is a chronic disease associated with increased morbidity and mortality. Bariatric surgery can lead to sustained long-term weight loss (WL) and improvement in multiple obesity-related complications, but it is not scalable at the population level. Over the past few years, gut hormone-based...